(Q44969924)

English

Our experience with 23 consecutive patients on gemcitabine/carboplatin chemotherapy for treatment of metastasized transitional cell carcinoma of the urothelium

scientific article published in July 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Our experience with 23 consecutive patients on gemcitabine/carboplatin chemotherapy for treatment of metastasized transitional cell carcinoma of the urothelium (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

based on heuristic

inferred from title

transitional cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Bernd Hoschke

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Matthias May

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Matthias Seehafer

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Christian Helke

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

International Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

461-466

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Familial aggregation of urothelial cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.0919-8172.2004.00846.X

21 January 2018

Current and future perspectives in advanced bladder cancer: is there a new standard?

1 reference

https://api.crossref.org/works/10.1111%2FJ.0919-8172.2004.00846.X

21 January 2018

Gemcitabine doublets in advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.0919-8172.2004.00846.X

21 January 2018

Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features

1 reference

https://api.crossref.org/works/10.1111%2FJ.0919-8172.2004.00846.X

21 January 2018

A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.0919-8172.2004.00846.X

21 January 2018

A feasibility study of carboplatin with fixed dose of gemcitabine in "unfit" patients with advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.0919-8172.2004.00846.X

21 January 2018

A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0919-8172.2004.00846.X

21 January 2018

Identifiers

10.1111/J.0919-8172.2004.00846.X

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44969924&oldid=2059877447"